Stephen DeWall

470 total citations
12 papers, 227 citations indexed

About

Stephen DeWall is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Stephen DeWall has authored 12 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Stephen DeWall's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Virus-based gene therapy research (2 papers) and Diabetes and associated disorders (2 papers). Stephen DeWall is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Virus-based gene therapy research (2 papers) and Diabetes and associated disorders (2 papers). Stephen DeWall collaborates with scholars based in United States, United Kingdom and Spain. Stephen DeWall's co-authors include Prafull Mistry, Juliet Reid, Blas Gil Extremera, Phil Ambery, Johanna Mora, Joleen T. White, Thomas N. Lee, Ann Schwartz, Tong‐Yuan Yang and Cindy Q. Xia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Stephen DeWall

12 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen DeWall United States 7 124 93 52 38 35 12 227
Nishanthi Thalayasingam United Kingdom 7 98 0.8× 103 1.1× 31 0.6× 54 1.4× 21 0.6× 10 308
Jorge A. Irizarry‐Caro United States 6 73 0.6× 82 0.9× 27 0.5× 31 0.8× 21 0.6× 16 209
Lidia Ostanek Poland 9 47 0.4× 139 1.5× 28 0.5× 26 0.7× 31 0.9× 39 296
Juan Estrada United States 8 110 0.9× 81 0.9× 87 1.7× 22 0.6× 37 1.1× 17 235
Ze Xiu Xiao China 8 92 0.7× 128 1.4× 33 0.6× 28 0.7× 26 0.7× 10 267
Eleni Nackos United States 5 59 0.5× 117 1.3× 58 1.1× 13 0.3× 24 0.7× 8 245
Izumi Kurata Japan 10 41 0.3× 119 1.3× 23 0.4× 20 0.5× 28 0.8× 19 268
Haili Shen China 12 125 1.0× 133 1.4× 27 0.5× 20 0.5× 9 0.3× 34 323
Annunziata Stefanile Italy 9 64 0.5× 58 0.6× 22 0.4× 13 0.3× 36 1.0× 21 259
Jennifer Ahlberg United States 8 71 0.6× 124 1.3× 16 0.3× 31 0.8× 48 1.4× 10 215

Countries citing papers authored by Stephen DeWall

Since Specialization
Citations

This map shows the geographic impact of Stephen DeWall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen DeWall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen DeWall more than expected).

Fields of papers citing papers by Stephen DeWall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen DeWall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen DeWall. The network helps show where Stephen DeWall may publish in the future.

Co-authorship network of co-authors of Stephen DeWall

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen DeWall. A scholar is included among the top collaborators of Stephen DeWall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen DeWall. Stephen DeWall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Henry, Susan A., Stephen DeWall, Ulka N. Vaishampayan, et al.. (2023). 726 Establishing proof of mechanism in patients: preliminary biomarker data of SRK-181 (a latent TGFβ1 inhibitor) from DRAGON Study. SHILAP Revista de lepidopterología. A821–A821. 1 indexed citations
2.
Yang, Tong‐Yuan, Manuela Braun, Fraser McBlane, et al.. (2022). Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper. Molecular Therapy — Methods & Clinical Development. 26. 471–494. 48 indexed citations
3.
Yap, Timothy A., Justin F. Gainor, Meredith McKean, et al.. (2022). 780 SRK-181, a latent TGFβ1 inhibitor: safety, efficacy, and biomarker results from the dose escalation portion of a phase I trial (DRAGON trial) in patients with advanced solid tumors. Regular and Young Investigator Award Abstracts. A812–A812. 1 indexed citations
4.
5.
Mora, Johanna, Joleen T. White, & Stephen DeWall. (2020). Immunogenicity Risk Assessment for PEGylated Therapeutics. The AAPS Journal. 22(2). 35–35. 15 indexed citations
6.
Morena, Francesco, Chiara Argentati, Serena Acquati, et al.. (2020). Toward Reference Intervals of ARSA Activity in the Cerebrospinal Fluid: Implication for the Clinical Practice of Metachromatic Leukodystrophy. The Journal of Applied Laboratory Medicine. 6(2). 354–366. 5 indexed citations
7.
Dettman, Elisha J., Fabio Rigat, Mary Birchler, et al.. (2018). Expression of Myeloma Cell and Soluble B-Cell Maturation Antigen (BCMA) in Relapsed and Refractory Multiple Myeloma Patients Treated with GSK2857916 in BMA117159. Blood. 132(Supplement 1). 1977–1977. 3 indexed citations
8.
9.
10.
Mistry, Prafull, Juliet Reid, Isabelle Pouliquen, et al.. (2014). Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects. International Journal of Clinical Pharmacology and Therapeutics. 52(10). 867–879. 34 indexed citations
11.
Schwartz, Ann, et al.. (2013). False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay. Journal of Immunological Methods. 394(1-2). 22–31. 22 indexed citations
12.
Sikkema, Dan, et al.. (2011). Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody. Journal of Immunological Methods. 375(1-2). 258–263. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nishanthi Thalayasingam Breakdown of academic impact, for papers by Jorge A. Irizarry‐Caro Breakdown of academic impact, for papers by Lidia Ostanek Breakdown of academic impact, for papers by Juan Estrada Breakdown of academic impact, for papers by Ze Xiu Xiao Breakdown of academic impact, for papers by Eleni Nackos Breakdown of academic impact, for papers by Izumi Kurata Breakdown of academic impact, for papers by Haili Shen Breakdown of academic impact, for papers by Annunziata Stefanile Breakdown of academic impact, for papers by Jennifer Ahlberg
Rankless by CCL
2026